A Leading Independent Proxy Advisory Firm, Glass Lewis, Recommends Shareholders Vote in Favor of the Proposed Merger Between 180 Degree Capital Corp. and Mount Logan Capital Inc.

(NasdaqGM:TURN), MONTCLAIR, N.J., July 30, 2025 (GLOBE NEWSWIRE) — 180 Degree Capital Corp. (NASDAQ: TURN) (“180 Degree Capital”) announced today that a leading independent proxy advisory firm, Glass, Lewis & Co. (“Glass Lewis”) has recommended that 180 Degree Capital shareholders vote “FOR” the proposed all-stock merger between 180 Degree Capital and Mount Logan Capital Inc. […]

BigCommerce and Feedonomics Deepen Partnership with Google Cloud, Empowering Merchants with Enhanced Discovery, Agentic Search Experiences and AI-Powered Data Enrichment

(NasdaqGM:BIGC), AUSTIN, Texas, July 30, 2025 (GLOBE NEWSWIRE) — BigCommerce (Nasdaq: BIGC), a leading open SaaS ecommerce platform for B2C and B2B businesses, and Feedonomics, a leading data feed management solution, today announced a deepened partnership with Google Cloud to accelerate merchant performance using Google Cloud's next-generation AI tools. The collaboration delivers powerful new capabilities

Capital Power announces second quarter 2025 results

(TSX:CPX),(TSX:CPX-PE),(TSX:CPX-PA),(TSX:CPX-PC),(TSX:CPX-PG),(TSX:CPX-PI),(TSX:CPX-PK),(TSX:CPX-PB), EDMONTON, Alberta, July 30, 2025 (GLOBE NEWSWIRE) — Capital Power Corporation (TSX: CPX) today released financial results for the quarter ended June 30, 2025. Highlights Completed previously announced acquisition of the Hummel and Rolling Hills facilities in the PJM1 market for ~$3.0 billion2 (US $2.2 billion), adding ~2.2 GW of capacity to its U.S.

ITW Reports Second Quarter 2025 Results

(NYSE:ITW), Revenue of $4.1 billion, an increase of 1% with flat organic growth Operating margin of 26.3% as enterprise initiatives contributed 130 bps GAAP EPS of $2.58, a new Q2 record Raising full year 2025 GAAP EPS guidance by $0.10; narrowing the range to $10.35 to $10.55 per share GLENVIEW, Ill., July 30, 2025 (GLOBE

Gnosis Launches EdenDx, the First Non-Invasive Liquid-Based Cytology U.S. Test for Early Endometrial Cancer Detection

Gnosis, a Southern California-based diagnostic lab advancing women's health through molecular innovation, today announced the national launch of EdenDx, which stands for Early Detection for Endometrial Neoplasia, the first commercially available non-invasive liquid-based cytology test in the United States for early-stage endometrial cancer detection. Endometrial cancer is the fourth most common cancer among women in

CPI Aerostructures Receives Follow-on Orders Totaling $2.4 Million for Welded Assemblies

(NYSE MKT:CVU), EDGEWOOD, N.Y., July 30, 2025 (GLOBE NEWSWIRE) — CPI Aerostructures, Inc. (“CPI Aero(R)” or the “Company”) (NYSE American: CVU) today announced that it has received follow-on orders from multiple existing customers totaling $2.4 million to weld complex structural assemblies used on a U.S. military helicopter. Deliveries are expected to occur through mid-2026. “CPI

LENZ Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

(NASDAQ:LENZ), New Drug Application (NDA) for LNZ100 for treatment of presbyopia on track for PDUFA target action date of August 8, 2025 88-member sales force hired and prepared to initiate sales and marketing activities immediately upon approval Executed multiple international license and commercialization agreements for LNZ100 including over $195 million in upfront and milestone payments

Corbus Pharmaceuticals Announces Upcoming Presentation of Dose Expansion Phase 1/2 Clinical Data for its Nectin-4 Targeting ADC CRB-701 at the 2025 ESMO Annual Congress

(NASDAQ:CRBP), NORWOOD, Mass., July 30, 2025 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, announced today that an abstract on updated clinical data from its Phase 1/2 clinical study conducted in the United States and Europe of CRB-701 (SYS6002) has been accepted for presentation as a

Kane Biotech Showcases revyve(TM) Preclinical and Clinical Case Study Findings at North American Wound Care Conferences

(TSX-V:KNE),(OTC US:KNBIF),(Other OTC:KNBIF), Clinical case series showed clinically meaningful reductions in wound size and pain, and improved tissue regranulation in chronic wound patients using revyve(R) over 6-12 weeks Preclinical in vitro studies demonstrated >80% reduction in protease activity, including complete inhibition of TACE and collagenase — key factors in non-healing chronic wounds revyve(R) data featured

Leopardo Energy, Town of Speedway announce utility plant partnership

INDIANAPOLIS, July 30, 2025 (GLOBE NEWSWIRE) — Leopardo Energy, in partnership with the Town of Speedway, has announced a biogas treatment system that will capture methane gas and convert it into energy at the local Speedway utility plant located at 4251 W. Vermont Street. Generating both electricity and heat from a single fuel source, Combined

Scroll to Top